Vertex Pharmaceuticals (VRTX)

$225.55 0.57 (0.25%)

16:24 EST VRTX Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 57.48B

PE Ratio 262.27

EPS 0.86

Volume (Avg. Vol.) 2.00M

Day's Range 224.39 - 227.60

52-Week Range 197.47 - 306.08

Dividend & Yield N/A (N/A)

VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News

From InvestorPlace
From the Web

4 Top Stocks to Buy in January

By Faisal Humayun Dec 30, 2020

These top stocks to buy in January have impending upside triggers and can be interesting to investors through 2021.

7 Cutting-Edge Biotech Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Oct 28, 2020

Biotech stocks are always going to be here, in good times and bad. Let's look at a few that are worth considering on the long side.

4 Top Stock Trades for Friday: ZM, DKNG, VRTX, GME

By Bret Kenwell, InvestorPlace Contributor Oct 15, 2020

Zoom Video, DraftKings, Vertex Pharma and GameStop were our top stock trades from Thursday. Here's a look at the charts.

Vertex Pharmaceuticals News: Why VRTX Stock Is Getting Slammed 20% Today

By William White, InvestorPlace Writer Oct 15, 2020

Vertex Pharmaceuticals (VRTX) news for Thursday concerning bad results from one of its clinical trials is sending VRTX stock down.

3 Nasdaq Stocks to Buy Off Their Corrective Bottoms

By Chris Tyler, InvestorPlace Contributor Sep 16, 2020

The best Nasdaq stocks to buy aren’t those with the biggest capitalization gains, but those whose shares have put in the work on the price chart.

5 Disruptive Biotech Stocks to Buy for the Future That Is Here

By Alex Sirois Aug 13, 2020

Biotech stocks are futuristic, but they're also bearing fruit now. So, check out these five hitting on trends and making investors money now.

7 Great Biotech Stocks to Buy and Hold Now

By Chris Markoch Jun 11, 2020

As investors begin to turn their attention away from Covid-19 and the novel coronavirus, these biotech stocks present excellent opportunities.

Vertex Pharmaceuticals Is a Biotech Play With No Coronavirus Exposure

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jun 2, 2020

VRTX stock is a biopharmaceutical with an A-Rating that has no stake in the risky race for a coronavirus treatment.

7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine

By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor May 22, 2020

Biotech stocks are in the spotlight in 2020, with the race to develop testing, treatment and a vaccine for Covid-19 driving rapid growth.

5 Biotech Stocks to Buy for a Strong Growth Prognosis

By Aaron Levitt, InvestorPlace Contributor Mar 11, 2020

The long-term outlook is rosy for these five biotech stocks. They have the pipelines, partners and marketed drugs to provide years of growth for investors.

Check Out These 5 Fast-Growing Stocks to Buy

By Louis Navellier, Editor, Growth Investor Nov 20, 2019

Growth is on a different track now, and here are some great ideas for stocks to buy to ride the momentum.

5 Healthcare Stocks to Buy

By William Roth, InvestorPlace Market Strategist Oct 22, 2019

Healthcare in particular is one such sector, with a number of large-cap biotechnology and pharmaceutical stocks enjoying fresh rallies.

5 Large-Cap Stocks With Growth in the Tank

By Laura Hoy, InvestorPlace Contributor Oct 8, 2019

Investors looking for the safety of large-cap stocks alongside impressive growth should consider these five investments.

3 Big Stock Charts for Friday: Conagra Brands, HollyFrontier and Vertex Pharmaceuticals

By James Brumley, InvestorPlace Feature Writer Sep 27, 2019

The stock charts of CAG, VRTX and HFC are poised to end the trading week in pivotal situations. Here's what you should know about each.

5 Goldman Sachs Stocks to Buy With Over 20% Upside Potential

By Harriet Lefton, Writer, TipRanks Sep 17, 2019

Here we take a closer look at five stocks with bullish calls from Goldman Sachs. As you will see, each of these stocks shows over 20% upside potential from current levels.

3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands

By James Brumley, InvestorPlace Feature Writer Aug 27, 2019

The stock charts of FTI, VRTX and STZ are knocking on the doors of major moves, even if the broad market isn't.

4 Biotech Stocks Sliding Lower

By William Roth, InvestorPlace Market Strategist Jul 26, 2019

Biotech stocks have been looking rough lately, and these four names have been helping to lead the charge lower.

3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals

By James Brumley, InvestorPlace Feature Writer Jul 12, 2019

The stock charts of HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals are poised to end the trading week in a pivotal situation.

10 Stocks That Are Screaming Buys Right Now

By Harriet Lefton, Writer, TipRanks Jun 27, 2019

Even in these unstable times, there are still gems to be found. And these are 10 of the hottest stocks on the Street, complete with "strong buy" analyst ratings and some compelling growth drivers.

7 Top-Rated Biotech Stocks to Invest In Today

By Louis Navellier, Editor, Growth Investor Jun 14, 2019

Despite the trade dispute with China, these biotech stocks each earn top marks in Portfolio Grader for fundamentals, earnings and momentum.

Navellier Ratings

Total Grade

Hold

Vertex Pharmaceuticals (VRTX)

VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News

Navellier Ratings

Total Grade

Subscriber Sign in